Transforming growth factor type (3 (TGF-f3), when injected subcutaneously in newborn mice, causes formation of granulation tissue (induction of angiogenesis and activation offibroblasts to produce collagen) at the site of injection.
TGF-(3 as an intrinsic mediator of collagen formation: conditioned media obtained from activated human tonsillar T lymphocytes contain greatly elevated levels of TGF-(3 compared to media obtained from unactivated lymphocytes. These activated media markedly stimulate proline incorporation into collagen in NRK cells; this effect is blocked by a specific antibody to TGF-(3. The data are all compatible with the hypothesis that TGF-fi is an important mediator of tissue repair.
Transforming growth factor type f (TGF-/3) was originally identified in neoplastic cells (1) (2) (3) (4) and then found in a wide variety of non-neoplastic tissues (1) (2) (3) (4) (5) ; the first total purification of this 25-kDa peptide was from three non-neoplastic sources-namely, human blood platelets, human placenta, and bovine kidney (6) (7) (8) . Recently, the human gene for TGF-A has been cloned (9) , and mRNA transcripts have been found in both neoplastic and non-neoplastic cells. There is a marked induction of TGF-,B mRNA when peripheral blood lymphocytes are activated (9) . The presence of TGF-,3 in cells or cell fragments of hematopoietic origin suggests that it may play some intrinsic role in inflammation and tissue repair. It had been shown previously that extrinsic TGF-f3 could stimulate the formation of connective tissue and collagen within wire-mesh wound-healing chambers implanted in rats (10, 11) . We now report that subcutaneous injection of < 1 1Lg ofTGF-,8 in newborn mice induces angiogenesis and causes rapid activation offibroblasts to produce collagen; the new tissue formed after injection of TGF-,B is essentially granulation tissue, resembling that found during physiological wound repair. Furthermore, we show that TGF-,3 in vitro has marked stimulatory effects on the formation of collagen by a variety of rodent and human fibroblasts and that these effects are different from those of two other peptide growth factors that have been implicated in tissue repair-namely, epidermal growth factor (EGF) and platelet-derived growth factor (PDGF).
Activated lymphocytes and macrophages have long been implicated in the production of growth factors that stimulate fibroblast proliferation and collagen synthesis, although the chemical nature of many of the specific peptide growth factors that are involved has not been well-defined (12) (13) (14) (15) (16) . Here, we report that T lymphocytes secrete greatly elevated levels of TGF-,B into their culture medium when they are activated in vitro (17) and that the conditioned media from such activated lymphocytes can stimulate proline incorporation into collagen in rodent fibroblasts. Moreover, we show that specific antibodies to TGF-p8 will partially abolish this stimulatory effect. The present data thus indicate that TGF-,p is a functionally significant component of the set of lymphokines produced by activated lymphocytes.
MATERIALS AND METHODS
Growth Factors. TGF-/3, homogeneous by analysis on sodium dodecyl sulfate/polyacrylamide gels, was purified from human platelets (6) . EGF was purified from male mouse salivary glands (1) . Pure human PDGF was the generous gift of Russell Ross and Elaine Raines and contained <0.1% TGF-P by radioreceptor assay (18) .
In Vivo Studies. Carrier-free sterile TGF-,p (40 gg) was dissolved in 200 p1L of 2 mM HCl to which 600 dul of phosphate-buffered saline (PBS) and 200 ,ul of PBS containing NaCl at 9 mg/ml was added. Swiss mice (1 day old) were injected subcutaneously each day in the nape ofthe neck with a 27-gauge needle, with 20 /il of TGF-,p or with saline control, and tissue samples were obtained as described in Results. Sterile murine EGF was also injected in the same vehicle in the same manner. At the end of each experiment, the firm nodular tissue at the site of injection of TGF-,p ( (17) . Serum-free HB-102 medium, conditioned by 106 cells per ml, was dialyzed against 1 M acetic acid, lyophilized, and reconstituted (20-to 50-fold more concentrated) in 4 mM HCl containing bovine serum albumin (1 mg/ml). Concentrations of TGF-p8 were determined both by a competitive radioreceptor assay measuring binding of 125I-labeled TGF-,B to A549 human lung carcinoma cells (18) and by comparison palpated at the injection site in mice dosed with TGF-,3. Such a lump was not seen in mice dosed with either EGF or saline; although EGF did not cause any direct response at the site of injection in these experiments, it was active in vivo, as measured by its ability to enhance eyelid opening (22, 23) . At the end of each experiment, the firm nodular tissue at the site of injection was removed and fixed in either neutral formalin or glutaraldehyde. Paraffin sections were then stained with either hematoxylin and eosin or Masson trichrome (for collagen). We have examined a total of 64 specimens from mice treated with TGF-A3; in every case, there has been a striking induction of the formation of new granulation tissue, as seen in Fig. 1 . Microscopic examination of the specimens from the mice treated with EGF showed no significant formation of any granulation tissue; these samples were virtually identical to the saline controls. As shown in Fig. 1 , there is both a fibrotic ( Fig. 1 B and C) and an angiogenic ( (Fig. 1B) ; this was confirmed by electron microscopy, which showed that TGF-13 (but neither EGF nor saline) treatment resulted in activation of rough endoplasmic reticulum in fibroblasts and production of extracellular collagen fibrils. Full details of these morphological observations will be published elsewhere.
The response to TGF-f3 is both dose and time dependent.
Daily injection of mice with 400 and 200 ng of TGF-/3 resulted in lesser, but detectable, responses when tissues were examined on the third day. Furthermore, the response to TGF-P3 is reversible; when mice were injected daily for 8 consecutive days with 800 ng of TGF-,8, a large area of granulation tissue was found, whereas injection of TGF-P for 3 days, followed by 5 days of rest, resulted in almost total disappearance of the granulation response. Neither EGF (800 ng daily) nor saline treatment for 8 days caused any significant granulation response.
In Vitro Studies. To obtain further information about the mechanism of action of TGF-,B in promoting the fibrotic response, we have performed an extensive series of experiments on cultured human and rat fibroblasts. As seen in Table  1 , early-passage human dermal fibroblasts respond to TGF-13 treatment with a selective stimulation of proline incorporation into collagen, as compared to noncollagen protein. Fig. 3 . Methylaminoisobutyric acid, an amino acid that is not metabolized, was chosen because it is taken up by cells by system A transport (26), the same system that accounts for proline and glycine uptake. Although all three growth factors stimulated methylaminoisobutyric acid uptake, TGF-,B alone increased incorporation of proline into collagen; thus, the differential effects of these growth factors on proline incorporation into collagen apparently are not the result of effects on amino acid uptake. Confirmation of these results is seen in Fig. 4 (9) and to secrete TGF-,B itself (17); there is a 10-to 30-fold increase in TGF-,8 in conditioned media of activated T lymphocytes compared to media obtained from unactivated lymphocytes (Fig. 5; ref. 17) . To test whether TGF-f3 secreted by lymphocytes might play an intrinsic role in formation of granulation tissue in vivo, we assayed the media conditioned by activated T lymphocytes for its ability to stimulate incorporation of proline into collagen. Fig. 5 shows that when lymphocytes are stimulated by phytohemagglutinin, there is a marked increase in both TGF-pB secretion and the ability of their conditioned medium to enhance the incorporation of [3H]proline into collagen. Although activated lymphocytes produce many growth factors other than TGF-p8 (12) (13) (14) (15) (16) Concentrations of TGF-,f in lymphocyte conditioned media (numbers in parentheses above) were determined both by assay of the soft agar colony-forming activity using NRK cells (1) and by a competitive radioreceptor binding assay using A549 cells (18) as described. Media were then assayed in the standard collagen assay using NRK cells, and the results were plotted against the TGF-13 concentrations determined above. As found previously for media conditioned by a variety of cells (29) , the TGF-,8 in media conditioned by lymphocytes was in an inactive latent form and required transient acid activation prior to assay.
The mechanism of action of TGF-0 in promoting collagen formation is similarly unknown. Certainly the increased numbers of fibroblasts at the site of injection (which might result from direct or indirect chemotactic actions of TGF-13 rather than direct proliferative actions) might be sufficient to explain the increased collagen deposition. However, in vitro experiments suggest a direct effect of TGF-P on collagen synthesis. Preliminary experiments suggest that TGF-P3 also increases formation of other matrix substances, such as glycosaminoglycans (V.F., unpublished results). In addition, although its functional implications are unknown, it may be noted that the TGF-,8 precursor contains the minimal cellular recognition sequence, Arg-Gly-Asp-X, identified in the adhesion glycoprotein, fibronectin (35 (36, 37) , and basic fibroblastic growth factor (32) , and that better understanding of its true role will require further study of these interactions.
